What is the main reason for this amended merger agreement?

The amended merger agreement primarily serves to update and extend critical deadlines for various filings required to complete the merger, such as the preliminary proxy statement for PHI and regulatory approvals from bodies like the Hart-Scott-Rodino Antitrust Improvements Act, the Federal Communication Commission, and the Maryland Public Service Commission. It also clarifies the treatment of certain executive equity awards.

Have the terms of the merger, specifically the price, changed?

No, the filing states that the terms and conditions of the Amended and Restated Merger Agreement are substantially the same as the original agreement, including the merger consideration to be paid to PHI stockholders. The changes focus on procedural timelines and equity award specifics, not the financial terms of the deal.

What are the new deadlines mentioned in the filing?

PHI's deadline to file its preliminary proxy statement has been moved from June 11, 2014, to July 24, 2014. The deadline for all Hart-Scott-Rodino, Federal Communication Commission, and Maryland Public Service Commission filings has been extended from June 28, 2014, to September 3, 2014.

What is the significance of the clarification regarding 'Company PSUs'?

The clarification ensures that certain Performance Stock Units (PSUs) required by agreements in place before the original merger announcement are treated as if granted before that date. This means they will not be subject to the pro-rata payout reduction that might apply to equity awards granted after the original merger agreement date, which is a detail relevant to executive compensation and potential dilution for shareholders.

EXC 8-K: Material Agreements

Summary

Exelon Corporation (EXC) filed an 8-K on July 21, 2014, to report an amendment to its merger agreement with Pepco Holdings, Inc. (PHI). The primary purpose of this amendment, dated July 18, 2014, was to revise key timelines and address certain equity award treatments related to the previously announced merger. While the core terms and merger consideration remain consistent with the original agreement, this filing signals ongoing progress and adjustments in the path toward closing the transaction. Investors should note the extension of several critical deadlines, including the preliminary proxy statement filing date for PHI and the dates for various regulatory filings. These adjustments may indicate complexities in obtaining necessary approvals or a strategic decision to accommodate further negotiations or reviews. The clarification regarding the treatment of certain equity awards (Company PSUs) is also a notable detail for stakeholders invested in executive compensation and potential dilution.

Key Highlights

1Exelon and Pepco Holdings, Inc. (PHI) entered into an Amended and Restated Agreement and Plan of Merger on July 18, 2014.
2The amendment primarily adjusts timelines for regulatory and shareholder-related filings.
3PHI's preliminary proxy statement filing deadline extended to July 24, 2014.
4Regulatory filing deadlines (HSR, FCC, Maryland PSC) extended to September 3, 2014.
5The core merger consideration to be paid to PHI stockholders remains unchanged.
6Clarification provided on the treatment of specific equity awards (Company PSUs) as pre-signing grants.
7The filing indicates ongoing progress and necessary adjustments in the merger process.

EXELON CORP 8-K Report, Material Agreement (Jul 21, 2014)

Summary

Key Highlights

Frequently Asked Questions